Cancer Immunology and Immunotherapy (Record no. 214815)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02589nam a22003975i 4500 |
001 - CONTROL NUMBER | |
control field | vtls004000410 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | UBDLIB |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20240608194900.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 130205s2011||||gw ||||||||||| |||||eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9783642141362 |
-- | 978-3-642-14136-2 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1007/978-3-642-14136-2 |
Source of number or code | doi |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (DE-He213)978-3-642-14136-2 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RC261-271 |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MJCL |
Source | bicssc |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MED062000 |
Source | bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 614.5999 |
Edition information | 23 |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Dranoff, Glenn. |
9 (RLIN) | 185954 |
245 10 - TITLE STATEMENT | |
Title | Cancer Immunology and Immunotherapy |
Medium | [electronic resource] / |
Statement of responsibility, etc. | edited by Glenn Dranoff. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | Berlin, Heidelberg : |
Name of publisher, distributor, etc. | Springer Berlin Heidelberg, |
Date of publication, distribution, etc. | 2011 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | XIII, 304p. 21 illus. in color. |
Other physical details | digital. |
490 0# - SERIES STATEMENT | |
Series statement | Current Topics in Microbiology and Immunology, |
International Standard Serial Number | 0070-217X ; |
Volume/sequential designation | 344 |
520 ## - SUMMARY, ETC. | |
Summary, etc. | The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that usher in a new era of cancer immunotherapy. These "first-in-class" treatments reflect the substantive progress that basic and translational scientists have made towards understanding the mechanisms underlying protective tumor immunity in cancer patients Immunotherapies were first explored at the turn of the twentieth century, but the crafting of potent treatments required more detailed knowledge of how the immune system responds to cancer. Advances in genetic, cellular, and biochemical technologies have begun to yield this critical information, focusing attention on immune recognition, regulation, and escape. Indeed, the dynamic interplay of these processes in the tumor microenvironment is now recognized to play a decisive role in determining disease outcome. This volume highlights the rapid progress and breadth of research in cancer immunology, and provides a framework for anticipating many more clinical successes in cancer immunotherapy. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Medicine. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Oncology. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunology. |
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biomedicine. |
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cancer Research. |
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunology. |
710 2# - ADDED ENTRY--CORPORATE NAME | |
Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
9 (RLIN) | 146659 |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Relationship information | Printed edition: |
International Standard Book Number | 9783642141355 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
Uniform title | Current Topics in Microbiology and Immunology, |
International Standard Serial Number | 0070-217X ; |
Volume/sequential designation | 344 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="http://dx.doi.org/10.1007/978-3-642-14136-2">http://dx.doi.org/10.1007/978-3-642-14136-2</a> |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | Library of Congress Classification |
No items available.